Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1989-1-13
|
pubmed:abstractText |
The purpose of this study was to further document the role of locally released norepinephrine (NE) in the control of metabolic and endocrine responses to exercise in rats. Post-ganglionic blockade with bretylium (20 mg.kg-1, i.v.) reduced NE release from sympathetic nerve endings and triggered a compensatory increase in epinephrine (E) release from the adrenal medulla, as reflected by plasma NE and E concentrations at rest and exercise (E/NE ratio = 2.92 +/- 0.53 and 2.48 +/- 0.51 vs 0.62 +/- 0.15 and 1.48 +/- 0.18 in control rats; mean +/- SE). Following bretylium administration a reduction in running time to exhaustion (28 m.min-1, 8% slope: 33 +/- 2 min vs 74 +/- 10 min) was associated with 1) a faster decrease in blood glucose concentration (3.58 +/- 0.80 mM vs 8.09 +/- 0.38 mM in control rats exercised for 33 min); and 2) an increased glycogen store utilization in fast-twitch muscles (superficial vastus lateralis and gastrocnemius lateralis). Glycogen utilization was not modified in soleus muscle and in the liver. Taken together these results suggest that post-ganglionic blockade increased carbohydrate store and peripheral blood glucose utilization. This could reflect an impairment in fat mobilization and utilization which might be secondary to a reduction of NE release in the adipose tissue and/or in the endocrine pancreas.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bretylium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Bretylium Tosylate,
http://linkedlifedata.com/resource/pubmed/chemical/Epinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Ganglionic Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0018-5043
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
546-50
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2904398-Animals,
pubmed-meshheading:2904398-Bretylium Compounds,
pubmed-meshheading:2904398-Bretylium Tosylate,
pubmed-meshheading:2904398-Epinephrine,
pubmed-meshheading:2904398-Ganglionic Blockers,
pubmed-meshheading:2904398-Glucagon,
pubmed-meshheading:2904398-Insulin,
pubmed-meshheading:2904398-Male,
pubmed-meshheading:2904398-Norepinephrine,
pubmed-meshheading:2904398-Physical Exertion,
pubmed-meshheading:2904398-Rats,
pubmed-meshheading:2904398-Rats, Inbred Strains
|
pubmed:year |
1988
|
pubmed:articleTitle |
Sympatho-endocrine and metabolic responses to exercise under post-ganglionic blockade in rats.
|
pubmed:affiliation |
Département d'éducation physique, Université de Montréal, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|